Speciality Medicines IPO GMP & Allotment
Speciality Medicines IPO is an SME public issue of a pharmaceutical company engaged in the marketing and distribution of specialty medicines, including high-cost drugs used for chronic and complex diseases. The IPO aims to raise funds primarily for business expansion and working capital needs. The issue opened on 20 March 2026 and is expected to raise around ₹29 crore, with a neutral grey market sentiment (GMP ~ ₹0) indicating cautious investor interest before listing. With growing demand for advanced healthcare treatments and specialty drugs, the company operates in a niche but expanding segment of the pharmaceutical industry, offering potential long-term growth opportunities.
- IPO Price Band
- ₹117.00 - ₹124.00
- Lot Size
- 1,000 Shares
- Bidding Closes
- 24 Mar 2026
- Listing Date
- 30 Mar 2026
Speciality Medicines IPO GMP Today & Key Takeaways
Speciality Medicines IPO officially listed on 30 Mar 2026 at Rs 124.00, delivering a +0.00% listing gain compared to its issue price of Rs 124.00. Pre-listing, its final recorded Grey Market Premium (GMP) was ₹0.
Speciality Medicines IPO officially listed on 30 Mar 2026 at ₹124.00, delivering a +0.00% listing gain compared to its issue price of ₹124.00. Pre-listing, its final recorded Grey Market Premium (GMP) was ₹0.
| Key Metric | Figure | Status / Context |
|---|---|---|
| Current GMP | ₹0 | +0% vs upper band (26 Mar 2026) |
| Est. Listing Price | ₹124.00 | +0.00% Est. Listing Gain |
| Price Band | ₹117.00 - ₹124.00 | SME IPO |
| Retail Minimum Investment | ₹2,48,000 | 2 Lot (1,000 Shares) |
| Bidding Window | 20 Mar 2026 – 24 Mar 2026 | Listed |
| Allotment & Listing Dates | Allotment: TBA | Listing: 30 Mar 2026 |
Complete IPO information
| IPO Open Date | 20 Mar 2026 |
|---|---|
| IPO Close Date | 24 Mar 2026 |
| IPO Price Band | ₹117.00 - ₹124.00 |
| Lot Size | 1,000 Shares |
| Current GMP | ₹0 |
| Estimated Listing Gain | +0.00% |
| Issue Size | - |
| Fresh Issue | - |
| Issue Type | SME |
| IPO Listing | NSE, BSE |
| Retail Quota | TBA |
| Registrar | TBA |
| Overall Subscription | 2.27x |
| Minimum Investment | ₹2,48,000 |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus | - |
IPO Snapshot & Investor Takeaways
At the upper end of its price band, Speciality Medicines is priced at ₹124 per share. With a minimum lot size of 1,000 shares, a retail investor applying for one lot would need approximately ₹2,48,000 to participate in this SME issue.
The latest recorded Grey Market Premium for Speciality Medicines stands at ₹0, implying an estimated listing gain of around 0.00% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
As of the latest update, Speciality Medicines's IPO was subscribed 2.27x overall, with a category-wise breakdown of Retail 0.85x, QIB 96.24x.
SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.
IPO roadmap at a glance
| Event / Milestone | Scheduled Date | Status |
|---|---|---|
| Bidding Opens | 20 Mar 2026 | Completed |
| Bidding Closes | 24 Mar 2026 | Completed |
| Allotment | TBA | Completed |
| Listing | 30 Mar 2026 | Completed |
Daily GMP status
| Date | GMP | Change | Gain |
|---|---|---|---|
| 26 Mar 2026 | ₹0.00 | - | 0.00% |
| 24 Mar 2026 | ₹0.00 | - | 0.00% |
| 23 Mar 2026 | ₹0.00 | - | 0.00% |
| 18 Mar 2026 | ₹0.00 | - | 0.00% |
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 Lot | 2,000 | ₹2,48,000 |
| Retail Maximum | 2 Lot | 2,000 | ₹2,48,000 |
| S-HNI Minimum | 3 Lot | 3,000 | ₹3,72,000 |
| S-HNI Maximum | 8 Lot | 8,000 | ₹9,92,000 |
| B-HNI Minimum | 9 Lot | 9,000 | ₹11,16,000 |
Objects of the Issue & Official Documents
IPO Reservation
| Investor Category | Shares Offered | Shares (%) |
|---|---|---|
| Anchor Investor | — Shares | —% |
| QIB (Ex. Anchor) | — Shares | 2% |
| NII Shares Offered | — Shares | 49% |
| Retail Shares Offered | — Shares | 49% |
Speciality Medicines IPO Anchor Investors
| Anchor Bidding Date | 2026 |
|---|---|
| Shares Offered | — Shares |
| Anchor Size | — Cr. |
| Lock-in Period (50% Shares - 30 Days) | 2026 |
| Lock-in Period (50% Shares - 90 Days) | 2026 |
Speciality Medicines IPO Dates
| Particular | Dates |
|---|---|
| IPO Open Date | 20 Mar 2026 |
| IPO Close Date | 24 Mar 2026 |
| Basis of Allotment | - |
| Refunds | - |
| Credit to Demat Account | - |
| IPO Listing Date | 30 Mar 2026 |
Note: The timeline for Speciality Medicines IPO is tentative and subject to change.
Promoters and Holding Pattern
| Promoters | Parth B Goyani and Goyani Sumit Babubhai |
|---|---|
| Promoter Holding Pre Issue | 64,35,796 Shares (59.28%) |
| Promoter Holding Post Issue | 87,85,796 Shares (43.44%) |
Speciality Medicines Objects of the Issue & Utilisation of Proceeds
To Be Updated Soon
Speciality Medicines Company Financials
To Be Updated Soon
Speciality Medicines Company Valuation – FY2026
To Be Updated Soon
Speciality Medicines IPO Peer Group Comparison
To Be Updated Soon
IPO Lead Managers aka Merchant Bankers
- Unicon Capital Services Pvt. Ltd.
Compare Speciality Medicines IPO with similar IPOs
Speciality Medicines IPO FAQs
Comments
Share a useful question or insight about Speciality Medicines.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Loading comments...